 | Up a level |
Number of items: 1.
Park, Julie R., Villablanca, Judith G., Hero, Barbara, Kushner, Brian H., Wheatley, Keith, Beiske, Klaus H., Ladenstein, Ruth L., Baruchel, Sylvain, Macy, Margaret E., Moreno, Lucas, Seibel, Nita L., Pearson, Andrew D., Matthay, Katherine K. and Valteau-Couanet, Dominique (2022). Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting. Cancer, 128 (21). S. 3775 - 3784. HOBOKEN: WILEY. ISSN 1097-0142